Medtronic plc logo
Medtronic plc (MDT)
Compare

Medtronic plc (MDT) Interest Expense

The interest expense for Medtronic plc (MDT) is $715.00 Million with a year-over-year change of -1.92%. Interest expense is the cost a company incurs for borrowed funds, including interest on bonds, loans, and other forms of debt financing.

MDT Interest Expense Chart

MDT Interest Expense
$715.00M
Zoom

Current Interest Expense

$715.00M

$715.00 Million

Year-over-Year Change

-1.92%

vs. $729.00M prior year

Historical Data

30

Years of data available

Annual Interest Expense History

YearInterest ExpenseYoY Change% Change
2026$715.00M$-14.00M-1.92%
2025$729.00M+$10.00M+1.39%
2024$719.00M+$83.00M+13.05%
2023$636.00M+$83.00M+15.01%
2022$553.00M$-372.00M-40.22%
2021$925.00M$-167.00M-15.29%
2020$1.09B$-352.00M-24.38%
2019$1.44B+$298.00M+26.00%
2018$1.15B+$52.00M+4.75%
2017$1.09B$-292.00M-21.07%
2016$1.39B+$720.00M+108.11%
2015$666.00M+$287.00M+75.73%
2014$379.00M$-9.00M-2.32%
2013$388.00M+$39.00M+11.17%
2012$349.00M$-101.00M-22.44%
2011$450.00M+$48.00M+11.94%
2010$402.00M+$31.00M+8.36%
2009$371.00M+$116.00M+45.49%
2008$255.00M+$255.00M
2007$0+$0
2006$0+$0
2005$0+$0
2004$0+$0
2003$0+$0
2002$0+$0
2001$0+$0
2000$0+$0
1999$0+$0
1998$0+$0
1997$0
Data as of Thursday, June 11, 2026

About Medtronic plc

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Galway
95,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Geoffrey Straub Martha